期刊文献+

冠心病慢性心力衰竭合并肺部感染者血清miRNA-155和miRNA-21的表达与意义 被引量:3

The expression of miRNA-155 and miRNA-21 in coronary artery disease patients with chronic heart failure and pulmonary infection and its clinical value
下载PDF
导出
摘要 目的分析冠心病慢性心力衰竭(下称心衰)合并肺部感染者的血清miRNA-155和miRNA-21表达及临床意义。方法选择2018年5月至2020年5月在金华市中医医院住院的冠心病慢性心衰合并肺部感染患者42例为观察组。选择同期冠心病慢性心衰不合并肺部感染患者44例为心衰组,健康体检者45例为对照组。采用实时荧光PCR技术测定血清miRNA-155和miRNA-21的表达水平。采用酶联免疫吸附法测定血清N末端脑钠肽前体(NT-proBNP)和超敏C反应蛋白(hs-CRP)水平。绘制ROC曲线,分析血清miRNA-155、miRNA-21、NT-proBNP和hs-CRP在冠心病慢性心衰合并肺部感染患者中的诊断效能。结果观察组血清miRNA-155、mi RNA-21、NT-proBNP和hs-CRP水平均高于心衰组和对照组,心衰组上述指标均高于对照组(均P<0.05)。血清miRNA-155、miRNA-21、NT-proBNP和hs-CRP水平联合测定在冠心病慢性心衰合并肺部感染患者中的诊断灵敏度高于上述4项单一检测,特异度低于上述4项指标单一检测(均P<0.05)。结论冠心病慢性心衰合并肺部感染患者血清miRNA-155和miRNA-21增高,结合NT-proBNP和hs-CRP有助于肺部感染的诊断。 Objective To investigate the expression of serum miRNA-155 and miRNA-21 in coronary artery disease(CAD)patients with chronic heart failure(CHF)and pulmonary infection(PI).Methods A total of 42 CAD patients with CHR and PI who admitted to Jinhua Hospital of TCM were selected as observation group from May 2018 to May 2020.Meanwhile,44 CAD patients with CHF were selected as CHF group and 45 healthy subjects as control group.Serum miRNA-155 and miRNA-21 were measured by real-time fluorescence PCR.Serum NT-proBNP and hs-CRP were measured by enzyme linked immunosorbent assay.ROC curve was drawn to analyze the diagnostic efficacy of serum miRNA-155,miRNA-21,NT-proBNP and hs-CRP in CAD patients with CHF and PI.Results Serum miRNA-155,miRNA-21,NT-proBNP and hs-CRP were significantly higher in observation group than in CHF group and the control group,and higher in CHF group than in the control group(all P<0.05).ROC curve analysis showed that combined miRNA-155,mi RNA-21,NT-proBNP and hs-CRP had significantly higher sensitivity and lower specificity in diagnosis of PI in CAD patients with CHF than any one of above 4 parameters(all P<0.05).Conclusion Serum miRNA-155 and miRNA-21 increase in CAD patients with CHF and PI,which may improve diagnosis of PI when combined with NT-proBNP and hs-CRP.
作者 蒋健刚 杜晓马 兰景良 晏程远 沈昕 JIANG Jiangang;DU Xiaoma;LAN Jingliang;YAN Chengyuan;SHEN Xin(Department of Cardiology,Jinhua Hospital of TCM,Jinhua 321000,China)
出处 《心电与循环》 2022年第3期279-283,共5页 Journal of Electrocardiology and Circulation
基金 金华市科技局科学研究基金项目(2018-4-103)。
关键词 miRNA-155 MIRNA-21 冠心病 慢性心力衰竭 肺部感染 miRNA-155 miRNA-21 Coronary heart disease Chronic heart failure Pulmonary infection
  • 相关文献

参考文献8

二级参考文献103

  • 1王力红,马文晖,张京利,石海鸥,崔晓华.APACHEⅡ评分与医院感染相关性研究[J].中华医院感染学杂志,2007,17(6):651-653. 被引量:42
  • 2Lawson WE, Hui JC, Lang G. Treatment benefit in the enhanced external counterpulsation consortium. Cardiology, 2000,94 ( 1 ) :31-35.
  • 3Ryden L, Standl E, Bartnic M, et al. Guideline on diabetes, prediabetes and cardiovascular disease:executive summary. The Task Force on Diabetes and Cardiovascular Disease of European Society of Cardiology (ESC) and of the Euopean Association for the Study of Diabetes(EASD). Eur Heart J,2007,28( 1 ) :88-136.
  • 4Crawford MH, Bernstein SJ, Deedwania PC, et al. ACC/AHA Guidelines for Ambulatory Electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( Committee to Revise the Guidelines for Ambulatory Electrocardiography). Developed in collaboration with the North American Society for Pacing and Electrophysiology.J Am Coll Cardiol,1999,34(3) :912-948.
  • 5Campeau L. Letter: Grading of angina pectoris. Circulation 1976 :54(3) :522-523.
  • 6O'Rourke RA, Brundage BH, Froelicher VF, et al. American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. J Am Coll Cardiol, 2000,36(1) :326-340.
  • 7Gibbons Pal, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-sunanary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol, 2003,41 ( 1 ) : 159-168.
  • 8Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation, 2004,110(10) :1245-1250.
  • 9Girman CJ, Rhodes T, Mercuri M,et al. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherescleresis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol,2004,93 ( 2 ) : 136-141.
  • 10Kjekshus JK, Maroko PB, Sobel BE. Distribution of myocardial injury and its relation to epicardial ST-segment changes after coronary artery occlusion in the dog. Cardiovasc Res,1972,6(5) :490-499.

共引文献6785

同被引文献35

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部